Literature DB >> 24729996

Care of the liver transplant patient.

Mamatha Bhat, Said Al-Busafi, Marc Deschênes, Peter Ghali.   

Abstract

OBJECTIVE: To provide an approach to the care of liver transplant (LT) patients, a growing patient population with unique needs.
METHODS: A literature search of PubMed for guidelines and review articles using the keywords "liver transplantation", "long term complications" and "medical management" was conducted, resulting in 77 articles.
RESULTS: As a result of being on immunosuppression, LT recipients are at increased risk of infections and must be screened regularly for metabolic complications and malignancies. DISCUSSION: Although immunosuppression is key to maintaining allograft health after transplantation, it comes with its own set of medical issues to follow. Physicians following LT recipients must be aware of the greater risk for hypertension, diabetes, dyslipidemia, renal failure, metabolic bone disease and malignancies in these patients, all of whom require regular monitoring and screening. Vaccination, quality of life, sexual function and pregnancy must be specifically addressed in transplant patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24729996      PMCID: PMC4071920          DOI: 10.1155/2014/453875

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


  57 in total

1.  Effect of orthotopic liver transplantation on employment and health status.

Authors:  C M Hunt; J S Tart; E Dowdy; B P Bute; D M Williams; P A Clavien
Journal:  Liver Transpl Surg       Date:  1996-03

Review 2.  Cardiovascular risk factors after liver transplantation.

Authors:  Santiago J Muñoz; Hisham Elgenaidi
Journal:  Liver Transpl       Date:  2005-11       Impact factor: 5.799

3.  Immunosuppression: evolution in practice and trends, 1994-2004.

Authors:  H-U Meier-Kriesche; S Li; R W G Gruessner; J J Fung; R T Bustami; M L Barr; A B Leichtman
Journal:  Am J Transplant       Date:  2006       Impact factor: 8.086

4.  Vaccination, screening for malignancy, and health maintenance of the liver transplant recipient.

Authors:  G A Zeldin; J Maygers; A Klein; P J Thuluvath
Journal:  J Clin Gastroenterol       Date:  2001-02       Impact factor: 3.062

Review 5.  Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.

Authors:  Anna L Taylor; Robert Marcus; J Andrew Bradley
Journal:  Crit Rev Oncol Hematol       Date:  2005-10       Impact factor: 6.312

6.  Sexual health after orthotopic liver transplantation.

Authors:  Jin K Ho; Hin Hin Ko; David F Schaeffer; Siegfried R Erb; Cherise Wong; Andrzej K Buczkowski; Charles H Scudamore; Eric M Yoshida
Journal:  Liver Transpl       Date:  2006-10       Impact factor: 5.799

7.  Proteinuria following a switch from calcineurin inhibitors to sirolimus.

Authors:  Emmanuel Letavernier; Marie-Noëlle Pe'raldi; Antoine Pariente; Emmanuel Morelon; Christophe Legendre
Journal:  Transplantation       Date:  2005-11-15       Impact factor: 4.939

8.  Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.

Authors:  Christophe Hézode; Françoise Roudot-Thoraval; Son Nguyen; Pascale Grenard; Boris Julien; Elie-Serge Zafrani; Jean-Michel Pawlotsky; Jean-Michel Pawlostky; Daniel Dhumeaux; Sophie Lotersztajn; Ariane Mallat
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

9.  Live virus immunization after orthotopic liver transplantation.

Authors:  Saba Khan; Jessi Erlichman; Elizabeth B Rand
Journal:  Pediatr Transplant       Date:  2006-02

10.  Weight change and obesity after liver transplantation: incidence and risk factors.

Authors:  J E Everhart; M Lombardero; J R Lake; R H Wiesner; R K Zetterman; J H Hoofnagle
Journal:  Liver Transpl Surg       Date:  1998-07
View more
  8 in total

1.  Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.

Authors:  Mohamad A Mouchli; Siddharth Singh; Edward V Loftus; Lisa Boardman; Jayant Talwalkar; Charles B Rosen; Julie K Heimbach; Russell H Wiesner; Bashar Hasan; John J Poterucha; Watt D Kymberly
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

Review 2.  Deep vein thrombosis during long-term surveillance of patients with liver transplantation.

Authors:  Alice Balaceanu
Journal:  Ir J Med Sci       Date:  2019-03-08       Impact factor: 1.568

3.  Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia.

Authors:  Faisal A Abaalkhail; Mohammed I Al Sebayel; Mohammed A Shagrani; Wael A O'Hali; Nasser M Almasri; Abduljaleel A Alalwan; Mohammed Y Alghamdi; Hamad Al-Bahili; Mohammed S AlQahtani; Saleh I Alabbad; Waleed K Al-Hamoudi; Saleh A Alqahtani
Journal:  Saudi Med J       Date:  2021-09       Impact factor: 1.422

4.  Belatacept Treatment of Recurrent Late-onset T Cell-mediated Rejection/Antibody-mediated Rejection With De Novo Donor-specific Antibodies in a Liver Transplant Patient.

Authors:  Göran B Klintmalm; James F Trotter; Anthony Demetris
Journal:  Transplant Direct       Date:  2022-06-24

Review 5.  The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient.

Authors:  Beje Thomas; Matthew R Weir
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

Review 6.  Succinct guide to liver transplantation for medical students.

Authors:  Cheng-Maw Ho; Po-Huang Lee; Wing Tung Cheng; Rey-Heng Hu; Yao-Ming Wu; Ming-Chih Ho
Journal:  Ann Med Surg (Lond)       Date:  2016-11-14

7.  The Impact of Socio-Demographic Factors on the Functioning of Liver Transplant Patients.

Authors:  Agnieszka Kisielska; Daria Schneider-Matyka; Kamila Rachubińska; Przemysław Ustanowski; Anita Rybicka; Elżbieta Grochans
Journal:  Int J Environ Res Public Health       Date:  2022-04-01       Impact factor: 3.390

8.  Quantitative assessment of liver fibrosis by digital image analysis reveals correlation with qualitative clinical fibrosis staging in liver transplant patients.

Authors:  Kun Jiang; Mohammad K Mohammad; Wasim A Dar; Jun Kong; Alton B Farris
Journal:  PLoS One       Date:  2020-09-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.